Goldman Sachs Invests US$20 Million in Ascletis
2015-12-03Dr. Jinzi Wu was Invited to Speak at 11th Annual Gates Foundation Grand Challenges Conference
2015-10-19Ascletis Secures US$35 Million Financing
2015-09-02Ascletis Initiates Phase II Clinical Trial of Its Interferon-Free HCV Regimen in Taiwan
2015-08-31Ascletis as the First Chinese Company to File Clinical Applications for Interferon-Free HCV Treatment
2015-06-24